Journal of Clinical Oncology (JCO) Podcast

The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ

Episodes

Total: 416

Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
2012/9/4

This podcast summarizes and places in clinical context two studies describing straightforward immuno

In a Sea of Data the Water is Still Murky: Meta-Analysis of Cognition in Breast Cancer
2012/8/27

Cognitive impairment occurs in a subset of breast cancer survivors after chemotherapy but the incide

KRAS G13D Mutations in Metastatic Colorectal Cancer: Are They Different From Codon 12?
2012/8/24

This podcast discusses the manuscript by Tejpar et al in which patients whose colorectal tumors harb

Taxane Induced Peripheral Neuropathy: A Continued Challenge but Not a Biomarker of Treatment Efficacy
2012/8/10

Although historically toxicity was often thought to be a biomarker of efficacy, often it appears to

Is This Nomogram Ready To Roll?
2012/6/25

In this podcast, Dr. Hudis reviews the use of a novel nomogram to predict the benefits of postoperat

Adjuvant Chemotherapy in Older Patients with Stage III Colon Cancer
2012/6/4

As oncologists treat an increasing number of older patients with colon cancer, and as treatment opti

The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma
2012/5/14

This podcast will provide a critical evaluation of the combination of bortezomib, thalidomide, and d

Personalized Therapy for Breast Cancer: Is It Really Happening?
2012/5/9

This Podcast reviews and comments on the use of the National Comprehensive Cancer Network (NCCN) Bre

Routine Second Pathology Review for Node-Negative Breast Cancer: What is Learned and What is the Effect on Patient Care?
2012/5/7

This Podcast reviews the design and results of the present study by Kennecke et al. and provides per

Pre-Operative Metformin in Early-Stage Breast Cancer
2012/5/7

This podcast reviews the rationale behind evaluation of metformin as a potential anti-cancer agent i

Fulvestrant and Anastrozole in Combination: FACT or Fiction?
2012/4/30

This podcast reviews the results of the FACT trial in the context of other ongoing and proposed stud

A New Day Dawning for Hodgkin Lymphoma?
2012/4/30

This podcast describes a phase 2 trial brentuximab vedotin in patients with Hodgkin lymphoma that ha

The German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow Up of 11 Years: Implications of Long Term Follow Up
2012/4/23

In this study, the implications of long term follow up of the German Rectal Study on clinical practi

Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
2012/4/23

Carboplatin-Gemcitabine-Bevacizumab represents an additional regimen to consider for management of r

The Use of Adjuvant Therapy in Elderly Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
2012/4/23

This podcast discusses adjuvant therapy in elderly NSCLC patients.

Management and Prevention of Pain Related to Treatment or Disease
2012/4/16

The podcast highlights recent JCO articles that underscore the need for improved assessment and mana

1 + 1 = 3. Combined Use of Anti-HER2 Agents in the Neoadjuvant Setting
2012/4/9

The CHER-LOB trial is one of several that has demonstrated that adding lapatinib to trastuzumab and

Management of Low Stage Ovarian Clear Cell Carcinoma
2012/4/9

A reflection on the problems clinicians face when making a decision on how best to advise patients r

Surviving Childhood Cancer: Defining Risk of Poor Cardiac Outcomes in Early and Middle Adulthood
2012/4/2

This podcast provides observations and commentary on the JCO article "High risk of symptomatic cardi

No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
2012/4/2

This podcast reviews a negative phase III clinical trial of cetuximab combined with chemotherapy in